By the Top Tier Newswire AI Desk · August 4, 2026 at 3:52 PM ET · reviewed against 7 wire stories
BRUKER CORP (BRKR) is down -21.84% in the latest session. Our newswire has captured 7 stories on BRKR across 5 sources in the last 36 hours, with AI sentiment reading bullish (avg 59/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Why BRKR stock is down today
BRKR stock fell 21.84% to $50.27 in a volatile session driven by a combination of earnings miss and downward revenue guidance. The stock opened with a modest gap up but quickly reversed course after the company reported Q2 revenue below estimates and cut its full-year sales outlook. The session saw heavy selling pressure, with the stock declining from a morning high of $64.96 to a low of $50.20.
What Happened
Bruker Corporation reported Q2 adjusted earnings per share of $0.49, which beat the $0.39 estimate. However, revenue came in at $838.5 million, missing the $853.5 million estimate. The company also reduced its full-year 2026 revenue guidance from $3.570 billion to $3.600 billion to $3.540 billion to $3.570 billion. Despite reaffirming its non-GAAP EPS guidance of $2.10 to $2.15, the revenue cut and a $20 million cost reduction target for FY2027 signaled ongoing challenges. The 10% organic growth in Scientific Instruments bookings was offset by softness in U.S. academic demand and a goodwill impairment charge.
The company’s updated guidance and earnings report came amid a broader market rally and positive performance in other healthcare stocks. However, Bruker’s mixed results and revised outlook led to a sharp sell-off. The session saw 5.8 million shares traded, more than double the 3-month average.
What The Data Shows
The stock’s 52-week range is $28.53 to $65.30, and it closed near the lower end of that range. The company has a market cap of $9.6 billion and remains unprofitable with a trailing twelve-month EPS of -0.24. Revenue growth has been flat at +0.4% TTM, and the net margin remains negative at -0.3%. The stock has a beta of 1.29, indicating higher volatility than the market. Recent insider transactions show three sales by Executive Vice President Mark Munch totaling $318,000 over the past 90 days.
What To Watch
The company is expected to report Q3 2026 earnings in the coming months. Investors should monitor coverage breadth and any further updates on cost reduction efforts and revenue performance.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
Bruker Corporation (BRKR) Q2 2026 Earnings Call Transcript
Bruker Corporation (BRKR) Q2 2026 Earnings Call August 4, 2026 9:00 AM EDTCompany ParticipantsJoe KostkaFrank Laukien - Chairman, CEO & PresidentGerald...
6d agoInvestorsHubBULLISH 63Earnings
Bruker Reports Second-Quarter 2026 Results as Scientific Instruments Bookings Accelerate
Bruker (NASDAQ:BRKR) reported Q2 2026 results with 5.2% revenue growth, 10% organic Scientific Instruments bookings growth, improved margins, and maintained its full-year non-GAAP EPS outlook.
6d agoMarketChameleonBULLISH 67Earnings
Bruker Delivers Strong Margin Expansion and EPS Growth Despite Soft US Academic Demand in Q2 2026
Bruker's second quarter shows robust non-GAAP profit growth, improved margins, and resilient bookings—even amid a notable goodwill impairment charge and ongoing sector headwinds. With updated 2026 guidance highlighting double-digit EPS growth and incremental organic gains, the company leverages strong order intake in semiconductors, energy research, and biopharma to offset academic softness.
6d agoSEC 8-KNEUTRAL 50General
BRUKER CORP (BRKRP) files 8-K
Filed: 2026-08-04 AccNo: 0001193125-26-331511 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
6d agoStockTitanBULLISH 63Earnings
Bruker Reports Second Quarter 2026 Financial Results
Scientific Instruments bookings rose 10% organically year over year. Bruker expects FY26 revenue of $3.54B-$3.57B and non-GAAP EPS of $2.10-$2.15.
7d agoSeeking AlphaBULLISH 56Earnings
Bruker Q2 2026 Earnings Preview
Bruker (BRKR) is scheduled to announce Q2 earnings results on Tuesday. The consensus EPS Estimate is $0.38 (+18.8% Y/Y) and the consensus Revenue Estimate is $8
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →